Last updated on October 2014

Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy


Brief description of study

Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy

Detailed Study Description

The purpose of this trial or study is to determine if cardiac resynchronization therapy (CRT) can be a benefit to people who have impaired heart function due to past treatment with chemotherapy and/or chest radiation. The investigators are looking to enroll approximately 100 eligible subjects with heart failure in this trial. All patients enrolled and registered in the study will be implanted with a cardiac resynchronization therapy device that includes an implantable cardiac defibrillator (CRT-D). Clinical histories, physical exams, and external device testing will be collected both at the time of enrollment in the trial and during follow-up study visits. Following implantation of the CRT-D, patients will be contacted by phone at 3 months and will have a scheduled clinic visit follow-up at 6 months.

Clinical Study Identifier: TX139399

Contact Investigators or Research Sites near you

Start Over

Bonnie Kirby

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa, FL USA
  Connect »